{
  "paper_metadata": {
    "pmid": "32862296",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5946delT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Ashkenazi Jews",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "98\u201399% of the PVs identified in Ashkenazi Jews are c.68_69delAG and c.5266dupC for BRCA1, and c.5946delT for BRCA2."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a high risk of breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Yes, it segregates with disease in families.",
      "population_frequency": "1 in 40 in Ashkenazi Jews",
      "evidence_level": "high",
      "source_location": "Table 1, Row 1",
      "additional_notes": "This variant is a founder mutation in Ashkenazi Jews.",
      "key_quotes": [
        "98\u201399% of the PVs identified in Ashkenazi Jews are c.68_69delAG and c.5266dupC for BRCA1, and c.5946delT for BRCA2."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3109C>T",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Southern Chinese",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "c.3109C>T is reported as 23% of BRCA1/2 mutations in Southern Chinese."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a significant risk of breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Yes, it segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Table 2, Row 1",
      "additional_notes": "This variant is prevalent in Southern Chinese populations.",
      "key_quotes": [
        "c.3109C>T is reported as 23% of BRCA1/2 mutations in Southern Chinese."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4037delC",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Filipinos",
        "phenotype": "breast and ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "c.4037delC is reported as 13% of BRCA1/2 mutations in Filipinos."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with a significant risk of breast and ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Yes, it segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Table 2, Row 3",
      "additional_notes": "This variant is prevalent in Filipino populations.",
      "key_quotes": [
        "c.4037delC is reported as 13% of BRCA1/2 mutations in Filipinos."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Reports of founder mutation (Caucasian)",
      "variants_extracted": 1
    },
    {
      "table_name": "Table 2",
      "table_caption": "Reports of founder mutation (Asian)",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}